相关参考文献
注意：仅列出部分参考文献，下载原文获取全部文献信息。Role of ING4 in human melanoma cell migration, invasion and patient survival
Jun Li et al.
CARCINOGENESIS (2008)
HER3 is a determinant for poor prognosis in melanoma
Markus Reschke et al.
CLINICAL CANCER RESEARCH (2008)
Major response to imatinib mesylate in KIT-mutated melanoma
F. Stephen Hodi et al.
JOURNAL OF CLINICAL ONCOLOGY (2008)
Adjuvant therapy with pegylated interferon alfa-2b versus observation alone in resected stage III melanoma:: final results of EORTC 18991, a randomised phase III trial
Alexander M. M. Eggermont et al.
LANCET (2008)
HSP90 as a marker of progression in melanoma
M. M. McCarthy et al.
ANNALS OF ONCOLOGY (2008)
DNA microarray analyses of melanoma gene expression: a decade in the mines
Keith S. Hoek
PIGMENT CELL RESEARCH (2007)
Evidence and interdisciplinary consense-based German guidelines: diagnosis and surveillance of melanoma
Claus Garbe et al.
MELANOMA RESEARCH (2007)
Errors in cancer diagnosis: Current understanding and future directions
Hardeep Singh et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Prognostic significance of nuclear ING3 expression in human cutaneous melanoma
Yemin Wang et al.
CLINICAL CANCER RESEARCH (2007)
Long-term protective effect of mature DC-LAMP+ dendritic cell accumulation in sentinel lymph nodes containing micrometastatic melanoma
Bruce Elliott et al.
CLINICAL CANCER RESEARCH (2007)
p53 stabilization can be uncoupled from its role in transcriptional activation by loss of PTTG1/Securin
Juan A. Bernal et al.
JOURNAL OF BIOCHEMISTRY (2007)
Clinical value of combined determination of plasma L-DOPA/tyrosine ratio, S100B, MIA and LDH in melanoma
Jean-Pierre Garnier et al.
EUROPEAN JOURNAL OF CANCER (2007)
Comparison of 3 tumor markers (MIA, TA90IC, S100B) in stage III melanoma patients
Mark B. Faries et al.
CANCER INVESTIGATION (2007)
Serologic and immunohistochemical prognostic biomarkers of cutaneous malignancies
Jochen Utikal et al.
ARCHIVES OF DERMATOLOGICAL RESEARCH (2007)
Bcl-2 antisense (oblimersen sodium) plus dacarbazine in patients with advanced melanoma: The oblimersen melanoma study group
Agop Y. Bedikian et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Prognostic significance of nuclear receptor coactivator-3 overexpression in primary cutaneous melanoma
Javier Rangel et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Expression and possible role of hPTTG1/securin in cutaneous malignant melanoma
Veronique Winnepenninckx et al.
MODERN PATHOLOGY (2006)
The US food and drug administration perspective on cancer biomarker development
Steven Gutman et al.
NATURE REVIEWS CANCER (2006)
Gene expression profiling of primary cutaneous melanoma and clinical outcome
VR Winnepenninckx et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2006)
Prognostic significance of autoimmunity during treatment of melanoma with interferon
H Gogas et al.
NEW ENGLAND JOURNAL OF MEDICINE (2006)
Serum YKL-40 predicts relapse-free and overall survival in patients with American Joint Committee on Cancer stage I and II melanoma
H Schmidt et al.
JOURNAL OF CLINICAL ONCOLOGY (2006)
Serum YKL-40, a new prognostic biomarker in cancer patients?
JS Johansen et al.
CANCER EPIDEMIOLOGY BIOMARKERS & PREVENTION (2006)
Serum proteomic fingerprinting discriminates between clinical stages and predicts disease progression in melanoma patients
S Mian et al.
JOURNAL OF CLINICAL ONCOLOGY (2005)
Analysis of differential gene expression in human melanocytic tumour lesions by custom made oligonucleotide arrays
NJW de Wit et al.
BRITISH JOURNAL OF CANCER (2005)
The gene expression signatures of melanoma progression
C Haqq et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Distinction of desmoplastic melanoma from non-desmoplastic melanoma by gene expression profiling
KJ Busam et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
Gene expression profile changes between melanoma metastases and their daughter cell lines: Implication for vaccination protocols
A Vogl et al.
JOURNAL OF INVESTIGATIVE DERMATOLOGY (2005)
The prognostic importance of tumor mitotic rate confirmed in 1317 patients with primary cutaneous melanoma and long follow-up
AB Francken et al.
ANNALS OF SURGICAL ONCOLOGY (2004)
Final version of the American Joint Committee on Cancer staging system for cutaneous melanoma
CM Balch et al.
JOURNAL OF CLINICAL ONCOLOGY (2001)
Rising levels of serum S100 protein precede other evidence of disease progression in patients with malignant melanoma
CS Jury et al.
BRITISH JOURNAL OF DERMATOLOGY (2000)
分享论文
